Why is Astrazeneca Phar falling/rising?

As of 29-Jul, Astrazeneca Pharma India Ltd's stock price is currently at 8,967.00, reflecting an increase of 39.95 (0.45%). The stock has been gaining for the last two days, with a total return of 1.48% during this period. However, it has underperformed its sector by 1% today. In terms of longer-term performance, the stock has shown a positive trend with a year-to-date return of 22.25% and a one-year return of 27.66%, significantly outperforming the BSE500 index. The company has demonstrated high management efficiency with a return on equity (ROE) of 19.06% and has reported strong net profit growth of 88.82% in its latest quarterly results. Despite these positives, the stock is trading at a premium valuation, which may raise concerns among investors.
In the broader market context, Astrazeneca's short-term performance has been relatively better than the benchmark, as it has gained 0.71% over the past month while the Sensex has declined by 3.24%. This indicates that the stock is holding up well compared to the overall market. However, the stock's recent gains come amidst a backdrop of falling investor participation, as evidenced by an 18.35% drop in delivery volume compared to the five-day average. This decline in liquidity could pose risks to sustained price increases. Overall, while Astrazeneca Pharma India Ltd has shown strong financial performance and resilience against market trends, concerns about its high valuation and reduced trading activity may temper future growth prospects.